Table 2. Summary of Contributing Factors on SVR12 Attainmenta.
Contributing Factor |
Attained SVR12 With Contributing Factor |
Attained SVR12 Without Contributing Factor |
P value |
|---|---|---|---|
Comorbidity |
|
|
|
Cirrhosis |
67% |
100% |
0.001 |
Diabetes |
68% |
83.7% |
0.303 |
Cardiovascular Disease |
77% |
81.25% |
0.728 |
Cognitive Impairment |
50% |
83.63% |
0.049 |
eGFR <60 ml/min |
84% |
80.95% |
0.608 |
|
SVR12 Attainment by Contributing Factor |
|
|
HCV Regimen |
Single Tablet Regimen |
Multi Tablet Regimen |
|
83.6% |
66.7% |
0.184 |
|
|
Treatment History |
Treatment Naive |
Treatment Experienced |
|
87% |
68% |
0.073 |
|
|
Pill Burden |
≥9 tablets/day |
<9 tablets/day |
|
82% |
79% |
0.655 |
|
Time to HCV Treatment |
<90 days |
≥90 days |
|
86.84% |
69.56% |
0.100 |
|
a
Factors evaluated using univariate analysis